[
    {
        "name": "Cardiology",
        "subtopics": [
            {
                "name": "Coronary artery disease",
                "questions": [
                    {
                        "question": "Which medications should be avoided in patients using nitrates?",
                        "choices": ["Sildenafil", "Aspirin", "Lisinopril", "Metoprolol"],
                        "correct_answer": "Sildenafil",
                        "explanation": "Sildenafil and other phosphodiesterase inhibitors [vardenafil, tadalafil] should be avoided in patients using nitrates because they can cause a dangerous drop in blood pressure due to their combined vasodilatory effects."
                    },                    
                    {
                        "question": "What is the proper use of nitrates in the management of angina to prevent tachyphylaxis?",
                        "choices": ["Use nitrates continuously without a break", "Establish a nitrate-free period of 8 to 12 hours per day", "Only use nitrates during physical activity", "Use nitrates only when other treatments fail"],
                        "correct_answer": "Establish a nitrate-free period of 8 to 12 hours per day",
                        "explanation": "To prevent nitrate tachyphylaxis, it is important to establish a nitrate-free period of 8 to 12 hours per day, typically overnight, during which nitrates are not used."
                    },
                    {
                        "question": "A patient with symptomatic coronary artery disease who is already on β-blockers and nitrates, BP at target, which other antianginal medication should be added?",
                        "choices": ["Ranolazine", "Furosemide", "Aspirin", "HCTZ"],
                        "correct_answer": "Ranolazine",
                        "explanation": "Ranolazine should be considered for patients with coronary artery disease who remain symptomatic despite optimal doses of β-blockers and nitrates"
                    },
                    {
                        "question": "When should ranolazine be avoided?",
                        "choices": ["In patients with uncontrolled hypertension", "In patients with a history of seizures", "In patients with liver cirrhosis", "In patients with QT prolongation"],
                        "correct_answer": "In patients with QT prolongation",
                        "explanation": "Ranolazine should be avoided in patients with bradycardia or prolonged QT interval, as it can exacerbate these conditions by further prolonging the QT interval and affecting heart rate."
                    },
                    {
                        "question": "Which of the following is NOT part of the four major classes of antianginal medications for stable angina?",
                        "choices": ["β-blockers", "Nitrates", "Calcium channel blockers", "Ranolazine", "ACE inhibitors"],
                        "correct_answer": "ACE inhibitors",
                        "explanation": "The four major classes of antianginal medications for stable angina are β-blockers, nitrates, calcium channel blockers, and ranolazine. ACE inhibitors  are not considered antianginal medications."
                    }                          
                ]
            },
            {
                "name": "Chest pain",
                "questions": [
                    {
                        "question": "A patient recently diagnosed with colon cancer, currently undergoing chemotherapy, presents to the ED with squeezing chest pain. Which medication may have contributed to this?",
                        "choices": ["Leucovorin", "5-Fluorouracil", "Oxaliplatin", "Zofran"],
                        "correct_answer": "5-Fluorouracil",
                        "explanation": "FOLFOX is a common chemotherapy regimen for colorectal cancer that includes leucovorin (folinic acid), 5-Fluorouracil (5-FU), and oxaliplatin. One of its components, 5-FU, can cause coronary vasospasms leading to myocardial ischemia. Patients may present with ECG changes such as ST-segment elevation and elevated troponin levels, indicating myocardial injury, even when angiography shows no occlusive coronary artery disease."
                    },
                    {
                        "question": "A young patient presents to the emergency department with chest pain and ST elevation on the initial ECG. After administration of aspirin and nitroglycerin, he is sent for cardiac catheterization. The patient exhibits anxiety, diaphoresis, tachycardia, and hypertension, and admits to recent cocaine use. What is the next best step?",
                        "choices": ["Thrombolytics", "Lorazepam IV", "Zofran", "Lisinopril"],
                        "correct_answer": "Lorazepam IV",
                        "explanation": "Lorazepam or other benzodiazepines are the treatment of choice for managing cocaine-induced chest pain and associated symptoms. They reduce anxiety, sympathetic hyperactivity, and the risk of arrhythmias or hypertension. Avoid beta-blockers as they can exacerbate coronary vasospasm."
                    }                    
                    
                ]
            },
            {
                "name": "Atrial fibrillation/flutter",
                "questions": [
                    {
                        "question": "Which arrhythmia is characterized by an irregularly irregular rhythm?",
                        "choices": ["Atrial Flutter", "Atrial Fibrillation", "Ventricular Tachycardia", "Sinus Arrhythmia"],
                        "correct_answer": "Atrial Fibrillation",
                        "explanation": "Atrial fibrillation is characterized by an irregularly irregular heart rhythm with no P waves."
                    },
                    {
                        "question": "Which of the following agents is NOT used for RATE CONTROL in a patient with atrial fibrillation?",
                        "choices": ["β-blockers", "Calcium channel blockers", "Digoxin", "Diuretics"],
                        "correct_answer": "Diuretics",
                        "explanation": "Rate control in atrial fibrillation is achieved by blocking the AV node, which can be done with β-blockers, calcium channel blockers, and digoxin. This slows the heart rate but does not convert the patient to sinus rhythm, which is typically achieved by rhythm control strategies."
                    },
                    {
                        "question": "How does digoxin achieve AV node blockage?",
                        "choices": ["Increases sympathetic tone", "Enhances vagal activity", "Blocks calcium channels", "Inhibits beta-receptors"],
                        "correct_answer": "Enhances vagal activity",
                        "explanation": "Digoxin slows AV node conduction by increasing parasympathetic (vagal) tone, reducing the heart rate."
                    },
                    {
                        "question": "A patient undergoing a routine ECG for unrelated reasons is found to have atrial fibrillation with rapid ventricular response (HR > 100 bpm). What complication may arise if the heart rate is not controlled?",
                        "choices": ["Mitral stenosis", "Ventricular septal defect", "Tachyarrhythmia-induced cardiomyopathy", "Pulmonary embolism"],
                        "correct_answer": "Tachyarrhythmia-induced cardiomyopathy",
                        "explanation": "Persistent rapid ventricular response in atrial fibrillation can lead to tachyarrhythmia-induced cardiomyopathy, characterized by left ventricular dysfunction due to sustained high heart rates. Although pulmonary emboism can happen with atrial fibrillation, it's very rare"
                    },
                    {
                        "question": "In a patient with atrial fibrillation and no significant valvular abnormality, how do you assess the need for anticoagulation?",
                        "choices": ["All patients need anticoagulation", "CHA2DS2-VASc score", "HEART score", "HAS-BLED score"],
                        "correct_answer": "CHA2DS2-VASc score",
                        "explanation": "The CHA2DS2-VASc score is used to assess stroke risk and guide the need for anticoagulation in patients with non-valvular atrial fibrillation."
                    },
                    {
                        "question": "A patient with atrial fibrillation comes to the ER complaining of lightheadedness. HR is 167 bpm and BP is 70/56 mmHg. What is your next step?",
                        "choices": ["Give Cardizem IV", "Cardioversion", "Defibrillation", "Give Metoprolol IV"],
                        "correct_answer": "Cardioversion",
                        "explanation": "In a patient with atrial fibrillation and signs of hemodynamic instability (e.g., hypotension, lightheadedness), immediate cardioversion is indicated to restore sinus rhythm and stabilize the patient."
                    },
                    {
                        "question": "A patient with newly diagnosed atrial fibrillation is found to have severe mitral stenosis on the echocardiogram. You decide to start the patient on anticoagulation. Which agent would you use?",
                        "choices": ["Rivaroxaban", "Warfarin", "Apixaban", "Dabigatran", "Edoxaban"],
                        "correct_answer": "Warfarin",
                        "explanation": "For patients with atrial fibrillation and severe mitral stenosis or a mechanical valve, warfarin is the only recommended anticoagulant due to its proven efficacy in these populations. Direct oral anticoagulants (DOACs) are not recommended due to the increased risk of thromboembolism."
                      }
                      
                ]
            }
        ]
    },
    {
        "name": "Rheumatology",
        "subtopics": [
            {
                "name": "Eosinophilic granulomatosis with polyangiitis",
                "questions": [
                    {
                        "question": "The prodromal phase of eosinophilic granulomatosis with polyangiitis [EGPA] is characterized by which of the following?",
                        "choices": ["Asthma and eosinophilia", "Hemoptysis and weight loss", "Rash and fever", "Joint pain and fatigue"],
                        "correct_answer": "Asthma and eosinophilia",
                        "explanation": "The prodromal phase of eosinophilic granulomatosis with polyangiitis [EGPA] is typically characterized by asthma and eosinophilia. This phase may precede the more severe vasculitic features of the disease."
                    },
                    {
                        "question": "Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by all of the following phases except for which?",
                        "choices": ["Prodromal phase", "Eosinophilic phase", "Vasculitic phase", "Lung phase"],
                        "correct_answer": "Lung phase",
                        "explanation": "Lung phase is not a recognized phase of EGPA, though pulmonary involvement occurs during other phases. EGPA phases occur as follows: 1. Prodromal phase characterized by asthma and eosinophilia. 2. Eosinophilic phase marked by tissue eosinophilia and systemic symptoms like fever and weight loss. 3. Vasculitic phase involves small-vessel vasculitis. "
                    },
                    {
                        "question": "Which of the following serologic markers is associated with eosinophilic granulomatosis with polyangiitis (EGPA)?",
                        "choices": ["p-ANCA [anti-MPO]", "c-ANCA [anti-PR3]", "ANA", "Anti-dsDNA"],
                        "correct_answer": "p-ANCA [anti-MPO]",
                        "explanation": "p-ANCA [anti-MPO] is associated with EGPA, although only about half of patients are positive for this marker."
                    }                   
                ]
            },
            {
                "name": "Systemic lupus erythematosus",
                "questions": [
                    {
                        "question": "In the diagnosis of lupus, what is the significance of an ANA test?",
                        "choices": ["ANA is positive in most lupus patients", "ANA is a specific marker for lupus", "ANA negative confirms lupus", "ANA is always negative in lupus"],
                        "correct_answer": "ANA is positive in most lupus patients",
                        "explanation": "In lupus, more than 95% of patients are ANA positive. If ANA is negative, it is unlikely to be lupus, as ANA is a sensitive but not specific marker for the disease."
                    }                    
                ]
            }
        ]
    },
    {
        "name": "Gastroenterology",
        "subtopics": [
            {
                "name": "Hemochromatosis",
                "questions": [
                    {
                        "question": "Why does iron deposition in tissues cause damage in hemochromatosis?",
                        "choices": ["Iron directly causes DNA mutations", "Iron overload leads to oxidative stress", "Iron interferes with calcium metabolism", "Iron accumulates in blood vessels, causing blockages"],
                        "correct_answer": "Iron overload leads to oxidative stress",
                        "explanation": "In hemochromatosis, excess iron accumulates in tissues and catalyzes the formation of free radicals, leading to oxidative stress, which damages cells, tissues, and organs."
                    }                    
                ]
            },
            {
                "name": "Acute pancreatitis",
                "questions": [
                    {
                        "question": "What is the most common cause of acute pancreatitis?",
                        "choices": ["Hypertriglyceridemia", "Alcohol consumption", "Drug-induced", "Scorpion sting"],
                        "correct_answer": "Alcohol consumption",
                        "explanation": "Alcohol consumption along with gallstones is the most common cause of acute pancreatitis."
                    },
                    {
                        "question": "Which of the following causes of acute pancreatitis is associated with hyponatremia?",
                        "choices": ["Hypercalcemia", "Hypertriglyceridemia", "Gallstones", "Endoscopic retrograde cholangiopancreatography"],
                        "correct_answer": "Hypertriglyceridemia",
                        "explanation": "Hypertriglyceridemia causes pseudohyponatremia by interfering with laboratory measurements in certain assays, leading to falsely low sodium levels due to plasma water displacement by excess lipids."
                    },
                    {
                        "question": "Which of the following is NOT a criterion for the diagnosis of acute pancreatitis?",
                        "choices": ["Epigastric abdominal pain", "Elevated lipase level 3x upper limit of normal", "Imaging findings of acute pancreatitis", "Fever"],
                        "correct_answer": "Fever",
                        "explanation": "Acute pancreatitis is diagnosed if the patient meets 2 out of 3 criteria: (a) epigastric abdominal pain, (b) lipase elevated 3x upper limit of normal, (c) imaging showing acute pancreatitis."
                    }                    
                ]
            }
        ]
    },
    {
        "name": "Pulmonology",
        "subtopics": [
            {
                "name": "Chronic obstructive pulmonary dsisease",
                "questions": [
                    {
                        "question": "Alpha-1 antitrypsin [AAT] deficiency usually involves which lobes of the lung?",
                        "choices": ["Upper lobes", "Lower lobes", "Doesn't affect the lung at all"],
                        "correct_answer": "Lower lobes",
                        "explanation": "Alpha-1 antitrypsin deficiency primarily affects the lower lobes of the lung due to the accumulation of neutrophil elastase activity, which damages the alveoli."
                    }
                    
                ]
            }
        ]
    },
    {
        "name": "Endocrinology",
        "subtopics": [
            {
                "name": "Diabetes mellitus",
                "questions": [
                    {
                        "question": "Which of the following diabetes medications causes vitamin B12 deficiency?",
                        "choices": ["Glipizide", "Metformin", "Empagliflozin", "Insulin glargine", "Semaglutide"],
                        "correct_answer": "Metformin",
                        "explanation": "Metformin is associated with vitamin B12 deficiency, particularly in long-term use. This is thought to be due to its effect on the small intestine, potentially impairing vitamin B12 absorption."
                    },
                    {
                        "question": "What is the hemoglobin A1c range for prediabetes?",
                        "choices": ["4.5%-5.6%", "5.7%-6.4%", "6.5%-7.0%", "7.1%-8.0%"],
                        "correct_answer": "5.7%-6.4%",
                        "explanation": "A hemoglobin A1c range of 5.7%-6.4% is indicative of prediabetes. A value of 6.5% or higher is diagnostic for diabetes."
                    },
                    {
                        "question": "In which of the following conditions will hemoglobin A1c be falsely low?",
                        "choices": ["Hemolytic anemia", "Hyperthyroidism", "Obesity", "Vitamin D deficiency"],
                        "correct_answer": "Hemolytic anemia",
                        "explanation": "Hemoglobin A1c can be falsely low in patients with hemolytic anemia because the shortened lifespan of red blood cells reduces the time available for glucose to attach to hemoglobin."
                    },
                    {
                        "question": "Which of the following antidiabetic medications is recommended for patients with heart failure?",
                        "choices": ["Metformin", "Sulfonylureas", "SGLT2 inhibitors", "DPP-4 inhibitors"],
                        "correct_answer": "SGLT2 inhibitors",
                        "explanation": "SGLT2 inhibitors are recommended for patients with heart failure as they have shown to reduce hospitalization rates and improve outcomes in heart failure patients, in addition to their effects on blood glucose control."
                    },
                    {
                        "question": "Which of the following medications should be considered in diabetic patients with established atherosclerotic cardiovascular disease (ASCVD) or at increased risk for ASCVD?",
                        "choices": ["Metformin", "GLP-1 receptor agonist", "Insulin", "Sulfonylureas"],
                        "correct_answer": "GLP-1 receptor agonist",
                        "explanation": "GLP-1 receptor agonists and SGLT2 inhibitors have been shown to reduce cardiovascular events in patients with established ASCVD or those at high risk, making them preferred treatment options in these populations."
                    },
                    {
                        "question": "When should screening for complications in patients with type 1 diabetes begin?",
                        "choices": ["Immediately after diagnosis", "1 year after diagnosis", "5 years after diagnosis", "10 years after diagnosis"],
                        "correct_answer": "5 years after diagnosis",
                        "explanation": "Screening for complications such as retinopathy, nephropathy, and neuropathy should begin 5 years after the diagnosis of type 1 diabetes, as these complications typically develop later in the course of the disease. Screening should start immediately after diagnosis in type 2 DM."
                    },
                    {
                        "question": "A patient presents to your office with polyuria, polydipsia, and fatigue. You check a serum glucose level and it’s 221 mg/dL. What do you tell the patient?",
                        "choices": ["You have diabetes mellitus for sure", "You need further testing", "Come back tomorrow to get tested again", "You don’t have diabetes mellitus"],
                        "correct_answer": "You have diabetes mellitus for sure",
                        "explanation": "Hyperglycemic symptoms such as polyuria, polydipsia, and fatigue with a random plasma glucose level ≥200 mg/dL with is diagnostic of diabetes mellitus"
                    },
                    {
                        "question": "A patient with type 1 diabetes mellitus presents with fatigue, nausea, and vomiting for the past 3 weeks. He has borderline low blood pressure, and his insulin requirements have decreased. Which of the following could be a possible explanation for his presentation?",
                        "choices": ["Adrenal failure", "Hyperthyroidism", "Myocardial infarction", "Pneumonia"],
                        "correct_answer": "Adrenal failure",
                        "explanation": "Patients with type 1 diabetes mellitus (autoimmune) are at increased risk of developing other autoimmune conditions, such as adrenal insufficiency. This can present with fatigue, nausea, vomiting, hypotension, and reduced insulin requirements."
                    },
                    {
                        "question": "Which of the following medications is NOT used for the treatment of diabetic nephropathy?",
                        "choices": ["Lisinopril", "Losartan", "Empagliflozin", "Finerenone", "Hydrochlorothiazide"],
                        "correct_answer": "Hydrochlorothiazide",
                        "explanation": "Hydrochlorothiazide is not used for the treatment of diabetic nephropathy and can potentially cause hyperglycemia. Lisinopril (ACE inhibitor), Losartan (ARB), Empagliflozin (SGLT2 inhibitor), and Finerenone (nonsteroidal mineralocorticoid receptor antagonist) are all used to manage diabetic nephropathy by reducing albuminuria and slowing disease progression."
                    },
                    {
                        "question": "Which of the following medications increases the risk for developing diabetes mellitus?",
                        "choices": ["Ondansetron", "Aspirin", "Amlodipine", "Atorvastatin"],
                        "correct_answer": "Atorvastatin",
                        "explanation": "Atorvastatin and other statins are associated with an increased risk of developing diabetes mellitus, particularly in patients with preexisting risk factors. Ondansetron (antiemetic), Aspirin (antiplatelet), and Amlodipine (calcium channel blocker) are not associated with an increased risk of diabetes."
                    } 
                ]
            }
        ]
    },
    {
        "name": "Neurology",
        "subtopics": [
            {
                "name": "Stroke",
                "questions": [
                    {
                        "question": "What is the next step in a patient who presents with right-sided weakness that started 30 minutes ago?",
                        "choices": ["CT head without contrast", "Chest x-ray", "Complete blood count", "CT angiogram of the chest"],
                        "correct_answer": "CT head without contrast",
                        "explanation": "The first step in stroke evaluation is a head CT scan without contrast, which is crucial for distinguishing ischemic from hemorrhagic stroke. This imaging rules out intracranial hemorrhage, a necessary step before considering thrombolytic therapy."
                    },
                    {
                        "question": "What is the next step in a patient who presents with right-sided weakness that started 30 minutes ago?",
                        "choices": ["MRI of the brain", "CT head with contrast", "Basic metabolic panel", "Fingerstick glucose"],
                        "correct_answer": "Fingerstick glucose",
                        "explanation": "A fingerstick glucose check should be performed to promptly rule out hypoglycemia, a stroke mimic, as the cause of neurological abnormalities. Since hypoglycemia is a readily reversible condition, early identification is crucial."
                    },
                    {
                        "question": "In a patient suspected of having a stroke, which imaging modality is the most sensitive for detection?",
                        "choices": ["CT head without contrast", "CT angiogram of head and neck", "MRI of the brain without contrast", "D-dimer"],
                        "correct_answer": "MRI of the brain without contrast",
                        "explanation": "MRI is the most sensitive imaging modality for detecting acute ischemic strokes because it can reveal cytotoxic edema, a critical sign of early infarction, within minutes of stroke onset."
                    },
                    {
                        "question": "In a patient presenting with right-sided weakness, dysphagia, and aphasia, with an unknown time of last known well and not amenable to endovascular therapy, what is the next best step in management?",
                        "choices": ["Oral aspirin", "Normalize blood pressure", "Acetaminophen", "Rectal aspirin"],
                        "correct_answer": "Rectal aspirin",
                        "explanation": "Aspirin is recommended within 24 to 48 hours of symptom onset in patients with acute ischemic stroke. In cases where dysphagia poses a risk for aspiration, rectal aspirin should be administered."
                    }                                          
                ]
            },
            {
                "name": "Parkinson Disease",
                "questions": [
                    {
                        "question": "Which of the following signs or symptoms is required for the diagnosis of Parkinson's disease?",
                        "choices": ["Muscle rigidity", "Bradykinesia", "Resting tremor", "Hallucinations"],
                        "correct_answer": "Bradykinesia",
                        "explanation": "For the diagnosis of Parkinson’s disease, the patient must exhibit bradykinesia, which is essential. In addition, at least one of the following must also be present: rigidity and/or resting tremor."
                    }             
                ]
            }
        ]
    },
    {
        "name": "Infectious Disease",
        "subtopics": [
            {
                "name": "Antibiotics",
                "questions": [
                    {
                        "question": "Which of the following antibiotics does NOT cover methicillin-resistant Staphylococcus aureus [MRSA]?",
                        "choices": ["Linezolid", "Vancomycin", "Ceftriaxone", "Daptomycin"],
                        "correct_answer": "Ceftriaxone",
                        "explanation": "Linezolid, vancomycin, and daptomycin cover MRSA. Ceftriaxone does not."
                    },
                    {
                        "question": "Which of the following antibiotics gets inactivated by lung surfactant?",
                        "choices": ["Ceftriaxone", "Azithromycin", "Daptomycin", "Vancomycin", "Rifampin"],
                        "correct_answer": "Daptomycin",
                        "explanation": "Daptomycin is inactivated by lung surfactant and therefore is ineffective for treating pneumonia."
                    },
                    {
                        "question": "Which of the following antibiotics should be used to treat methicillin-susceptible Staphylococcus aureus (MSSA)?",
                        "choices": ["Vancomycin", "Nafcillin", "Rifampin", "Azithromycin"],
                        "correct_answer": "Nafcillin",
                        "explanation": "Nafcillin and cefazolin are the preferred treatments for MSSA due to superior efficacy. Vancomycin can treat MSSA but is less effective than beta-lactams like nafcillin or cefazolin."
                    },
                    {
                        "question": "A patient is on daptomycin for MRSA endocarditis. Which laboratory test should be monitored?",
                        "choices": ["Liver function tests", "Creatine kinase", "Complete blood count", "Serum potassium"],
                        "correct_answer": "Creatine kinase",
                        "explanation": "Daptomycin can cause muscle toxicity, including rhabdomyolysis, so creatine kinase [CK] levels should be monitored weekly during therapy."
                    } 
                ]
            },
            {
                "name": "Cryptococcal infection",
                "questions": [
                    {
                        "question": "How is cryptococcal meningitis diagnosed?",
                        "choices": ["CT scan of the head", "Detection of cryptococcal antigen in CSF", "Blood culture", "CD4 count < 200/µL"],
                        "correct_answer": "Detection of cryptococcal antigen in CSF",
                        "explanation": "The diagnosis of cryptococcal meningitis is based on the detection of cryptococcal antigen in the CSF or culture of Cryptococcus neoformans from the CSF."
                    },                    
                    {
                        "question": "What is the treatment for cryptococcal meningitis?",
                        "choices": ["Amphotericin B plus flucytosine", "Vancomycin and ceftriaxone", "Fluconazole monotherapy", "Amphotericin B monotherapy"],
                        "correct_answer": "Amphotericin B plus flucytosine",
                        "explanation": "The treatment for cryptococcal meningitis involves induction with amphotericin B plus flucytosine"
                    },
                    {
                        "question": "Which drug is used as a maintenance agent for cryptococcal meningitis?",
                        "choices": ["Flucytosine", "Amphotericin B", "Fluconazole", "Vancomycin"],
                        "correct_answer": "Fluconazole",
                        "explanation": "Fluconazole is the preferred maintenance agent for cryptococcal meningitis following initial induction-treatment with amphotericin B and flucytosine."
                    },
                    {
                        "question": "How long should maintenance therapy be continued for cryptococcal meningitis in HIV-infected patients?",
                        "choices": ["6 months", "1 year", "2 years", "Until symptoms resolve"],
                        "correct_answer": "1 year",
                        "explanation": "Maintenance therapy should be continued for at least 1 year and until the patient's CD4 count is greater than 100/µL with an undetectable viral load."
                    }                    
                ]
            },
            {
                "name": "Tick-borne disease",
                "questions": [
                    {
                        "question": "What is the treatment of choice for human monocytic ehrlichiosis [HME] and human granulocytic anaplasmosis [HGA]?",
                        "choices": ["Azithromycin", "Ceftriaxone", "Doxycycline", "Amoxicillin"],
                        "correct_answer": "Doxycycline",
                        "explanation": "Doxycycline is the treatment of choice for both human monocytic ehrlichiosis [HME] and human granulocytic anaplasmosis [HGA]."
                    }
                    
                ]
            }
            
        ]
    }
]
